Related topics

Alder BioPharmaceuticals: 2Q Earnings Snapshot

August 7, 2018

BOTHELL, Wash. (AP) _ Alder BioPharmaceuticals Inc. (ALDR) on Tuesday reported a loss of $68.4 million in its second quarter.

On a per-share basis, the Bothell, Washington-based company said it had a loss of $1.04.

The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of $1.14 per share.

Alder BioPharmaceuticals shares have climbed 69 percent since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $19.40, more than doubling in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ALDR at https://www.zacks.com/ap/ALDR

Update hourly